Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1 Kuchena >99.0% (HPLC) Olmesartan Medoxomil Intermediate Factory

Tsanangudzo Pfupi:

Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate

CAS: 144689-94-1

Kuchena:> 99.0% (HPLC)

Chitarisiko: Yero Yakacheneruka kusvika Kusiri-Ichena Powder

Pakati peOlmesartan Medoxomil

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate
Mashoko anoreva zvakafanana Diethyl 2-PropylImidazoledicarbonate;2-Propyl-1H-Imidazole-4,5-Dicarboxylic Acid Diethyl Ester;2-Propylimidazoledicarboxylic Acid Diethyl Ester
Nhamba yeCAS 144689-94-1
Nhamba yeCAT RF-PI1872
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C12H18N2O4
Molecular Weight 254.29
Density 1.160±0.06 g/cm3
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Yero Yero kusvika kuOff-White Powder
Kuchena / Analysis Method >99.0% (HPLC)
Melting Point 83.0~88.0℃
Zvemumvura (KF) <0.50%
Residue paIgnition <0.20%
Maximum Single Kusachena <0.50%
Zvose Zvisina Kuchena <1.00%
Proton NMR Spectrum Inopindirana neChimiro
Test Standard Enterprise Standard
Usage Pakati peOlmesartan Medoxomil (CAS: 144689-63-4)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

1

FAQ:

Application:

Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate (CAS: 144689-94-1) iri pakati pekubatanidzwa kweOlmesartan Medoxomil (CAS: 144689-63-4).Olmesartan Medoxomil inoratidzirwa pakurapa kweBP (hypertension).Kuderedza high blood pressure kunobatsira kudzivirira sitiroko, heart attack, uye matambudziko eitsvo.Olmesartan ndeyekirasi yemishonga inonzi angiotensin receptor blockers (ARBs).Olmesartan inoshanda nekuzorodza tsinga dzeropa kuitira kuti ropa rifambe zviri nyore.Inogona kushandiswa yoga kana kusanganiswa nemamwe antihypertensive agents.Iyo US Chikafu neDrug Administration (FDA) yakaona kuti mabhenefiti eBenicar arambe achipfuura njodzi dzinogona kuitika kana ichishandiswa kurapa varwere vane high blood pressure maererano neiyo drug label.

Nyora meseji yako pano uye titumire kwatiri